Perfluorocarbon attenuates response of concanavalin A-stimulated mononuclear blood cells without altering ligand-receptor interaction

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 287, Issue 1 31-1, 2004, Pages

  Haufe, Dirk ^a   Luther, Thomas ^b   Kotzsch, Matthias ^b   Knels, Lilla ^a   Koch, Thea ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Acute lung injury; Anti inflammatory; Cell surface receptor; Immune cells

Indexed keywords

CELL SURFACE RECEPTOR; CONCANAVALIN A; FLUOROCARBON; INTERLEUKIN 2; LIGAND; THROMBOPLASTIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LEUKOCYTE FUNCTION; LUNG INJURY; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

BIOCOMPATIBLE MATERIALS; CELL MEMBRANE; CONCANAVALIN A; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; FLUOROCARBONS; HUMANS; INTERLEUKIN-2; MICROSCOPY, FLUORESCENCE; MONOCYTES; RECEPTORS, CELL SURFACE; THROMBOPLASTIN;

EID: 2942704080     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00432.2003     Document Type: Article

References (40)

1. Albertini DF and Anderson E. Microtubule and microfilament rearrangements during capping of concanavalin A receptors on cultured ovarian granulosa cells. J Cell Biol 73: 111-127, 1977.
2. Albrecht S, Kotzsch M, Siegert G, Luther T, Grossmann H, Grosser M, and Muller M. Detection of circulating tissue factor and factor VII in a normal population. Thromb Haemost 75: 772-777, 1996.
3. Baba A, Kim YK, Zhang H, Liu M, and Slutsky AS. Perfluorocarbon blocks tumor necrosis factor-α-induced interleukin-8 release from alveolar epithelial cells in vitro. Crit Care Med 28: 1113-1118, 2000.
4. Babbitt DG, Forman MB, Jones R, Bajaj AK, and Hoover RL. Prevention of neutrophil-mediated injury to endothelial cells by perfluorochemical. Am J Pathol 136: 451-459, 1990.
5. Brain JD, Molina RM, DeCamp MM, and Warner AE. Effects of a perfluorochemical emulsion on the fate of circulating Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol 276: L1037-L1045, 1999.
6. Caiazza S, Fanizza C, and Ferrari M. Fluosol 43 particle localization pattern in target organs of rats. An electron microscopy study. Virchows Arch 404: 127-137, 1984.
7. Colton DM, Till GO, Johnson KJ, Dean SB, Bartlett RH, and Hirschl RB. Neutrophil accumulation is reduced during partial liquid ventilation. Crit Care Med 26: 1716-1724, 1998.
8. Croce MA, Fabian TC, Patton JH Jr, Melton SM, Moore M, and Trenthem LL. Partial liquid ventilation decreases the inflammatory response in the alveolar environment of trauma patients. J Trauma 45: 273-280, 1998.
9. De Petris S. Concanavalin A receptors, immunoglobulins, and theta antigen of the lymphocyte surface. Interactions with concanavalin A and with cytoplasmic structures. J Cell Biol 65: 123-146, 1975.
10. Ellena JF, Obraztsov VV, Cumbea VL, Woods CM, and Cafiso DS. Perfluorooctyl bromide has limited membrane solubility and is located at the bilayer center. Locating small molecules in lipid bilayers through paramagnetic enhancements of NMR relaxation. J Med Chem 45: 5534-5542, 2002.
11. Fernandez R, Sarma V, Younkin E, Hirschl RB, Ward PA, and Younger JG. Exposure to perflubron is associated with decreased Syk phosphorylation in human neutrophils. J Appl Physiol 91: 1941-1947, 2001.
12. Forman MB, Pitarys CJ, Vildibill HD, Lambert TL, Ingram DA, Virmani R, and Murray JJ. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion. J Am Coll Cardiol 19: 205-216, 1992.
13. Gunnarson B, Rich GA, and Steinhorn DM. Perfluorocarbon (PFC) affects receptor-ligand binding in neutrophils (PMNs) after in vitro exposure. Crit Care Med 26, Suppl 1: 27A, 1998.
14. Heard SO and Puyana JC. The anti-inflammatory effects of perfluorocarbons: let's get physical. Crit Care Med 28: 1241-1242, 2000.
15. Hirschl RB, Croce M, Gore D, Wiedemann H, Davis K, Zwischenberger J, and Bartlett RH. Prospective, randomized, controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome. Am J Respir Crit Care Med 165: 781-787, 2002.
16. Hirschl RB, Pranikoff T, Wise C, Overbeck MC, Gauger P, Schreiner RJ, Dechert R, and Bartlett RH. Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome. JAMA 275: 383-389, 1996.
17. Hirschl RB, Tooley R, Parent A, Johnson K, and Bartlett RH. Evaluation of gas exchange, pulmonary compliance, and lung injury during total and partial liquid ventilation in the acute respiratory distress syndrome. Crit Care Med 24: 1001-1008, 1996.
18. Ingram DA, Forman MB, and Murray JJ. Phagocytic activation of human neutrophils by the detergent component of fluosol. Am J Pathol 140: 1081-1087, 1992.
19. Koch T, Ragaller M, Haufe D, Hofer A, Grosser M, Albrecht DM, Kotzsch M, and Luther T. Perfluorohexane attenuates proinflammatory and procoagulatory response of activated monocytes and alveolar macrophages. Anesthesiology 94: 101-109, 2001.
20. Kurrasch R, Elfman F, and Perez HD. Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4. J Immunol 143: 1969-1973, 1989.
21. Leach CL, Greenspan JS, Rubenstein SD, Shaffer TH, Wolfson MR, Jackson JC, DeLemos R, and Fuhrman BP. Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. The LiquiVent Study Group. N Engl J Med 335: 761-767, 1996.
22. Max M, Kuhlen R, Lopez F, Reyle-Hahn SM, Baumert JH, and Rossaint R. Combining partial liquid ventilation and prone position in experimental acute lung injury. Anesthesiology 91: 796-803, 1999.
23. Nakstad B, Wolfson MR, Shaffer TH, Kahler H, Lindemann R, Fugelseth D, and Lyberg T. Perfluorochemical liquids modulate cell-mediated inflammatory responses. Crit Care Med 29: 1731-1737, 2001.
24. Obraztsov VV, Neslund GG, Kornbrust ES, Flaim SF, and Woods CM. In vitro cellular effects of perfluorochemicals correlate with their lipid solubility. Am J Physiol Lung Cell Mol Physiol 278: L1018-L1024, 2000.
25. Osterud B. Tissue factor: a complex biological role. Thromb Haemost 78: 755-758, 1997.
26. Rossman JE, Caty MG, Rich GA, Karamanoukian HL, and Azizkhan RG. Neutrophil activation and chemotaxis after in vitro treatment with perfluorocarbon. J Pediatr Surg 31: 1147-1150, 1996.
27. Rotta AT, Gunnarsson B, Hernan LJ, Fuhrman BP, and Steinhorn DM. Partial liquid ventilation with perflubron attenuates in vivo oxidative damage to proteins and lipids. Crit Care Med 28: 202-208, 2000.
28. Rotta AT and Steinhorn DM. Partial liquid ventilation reduces pulmonary neutrophil accumulation in an experimental model of systemic endotoxemia and acute lung injury. Crit Care Med 26: 1707-1715, 1998.
29. Schoof E, von der Hardt K, Kandler MA, Abendroth F, Papadopoulos T, Rascher W, and Dotsch J. Aerosolized perfluorocarbon reduces adhesion molecule gene expression and neutrophil sequestration in acute respiratory distress. Eur J Pharmacol 457: 195-200, 2002.
30. Sharon N and Lis H. Lectins: cell-agglutinating and sugar-specific proteins. Science 177: 949-959, 1972.
31. Sheterline P and Hopkins CR. Transmembrane linkage between surface glycoproteins and components of the cytoplasm in neutrophil leukocytes. J Cell Biol 90: 743-754, 1981.
32. Smith TM, Steinhorn DM, Thusu K, Fuhrman BP, and Dandona P. A liquid perfluorochemical decreases the in vitro production of reactive oxygen species by alveolar macrophages. Crit Care Med 23: 1533-1539, 1995.
33. Steinhorn DM, Leach CL, Fuhrman BP, and Holm BA. Partial liquid ventilation enhances surfactant phospholipid production. Crit Care Med 24: 1252-1256, 1996.
34. Thomassen MJ, Buhrow LT, and Wiedemann HP. Perflubron decreases inflammatory cytokine production by human alveolar macrophages. Crit Care Med 25: 2045-2047, 1997.
35. Varani J, Hirschl RB, Dame M, and Johnson K. Perfluorocarbon protects lung epithelial cells from neutrophil-mediated injury in an in vitro model of liquid ventilation therapy. Shock 6: 339-344, 1996.
36. Von der Hardt K, Kandler MA, Fink L, Schoof E, Dotsch J, Bohle RM, and Rascher W. Laser-assisted microdissection and real-time PCR detect anti-inflammatory effect of perfluorocarbon. Am J Physiol Lung Cell Mol Physiol 285: L55-L62, 2003.
37. Von der Hardt K, Schoof E, Kandler MA, Dotsch J, and Rascher W. Aerosolized perfluorocarbon suppresses early pulmonary inflammatory response in a surfactant-depleted piglet model. Pediatr Res 51: 177-182, 2002.
38. Weinbaum DL, Sullivan JA, and Mandell GL. Receptors for concanavalin A cluster at the front of polarized neutrophils. Nature 286: 725-727, 1980.
39. Wiryawan B, Dowhy MS, Fuhrman BP, and Rotta AT. Perfluorochemical (PFC) attenuation of oxidative injury is proportional to lipid solubility (Abstract). Eur J Med Res 8: 177, 2004.
40. Woods CM, Neslund G, Kornbrust E, and Flaim SF. Perflubron attenuates neutrophil adhesion to activated endothelial cells in vitro. Am J Physiol Lung Cell Mol Physiol 278: L1008-L1017, 2000.